🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot trial in Finland is designed to evaluate in a randomized fashion...
Status
Terminated
Location
Research Site
Start Date
2008-09
Trial ID
NCT00660595
Treatments Being Tested
The study will assess the use of paliperidone palmitate compared with oral ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01193166
The purpose of this study is to evaluate symptomatic remission rate in pati...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00216528
Treatments Being Tested
The purpose of this study is to evaluate a bundled intervention of psychotr...
Status
Completed
Location
Mount Horeb Prayer Centre
Start Date
2013-07
Trial ID
NCT02593734
Treatments Being Tested
The purpose of this study is to evaluate the long-term efficacy and safety ...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00269919
Treatments Being Tested
As many as 75 percent of patients with schizophrenia have difficulty taking...
Status
Completed
Location
John Umstead Hospital
Start Date
2004-04
Trial ID
NCT00215579
Treatments Being Tested
A Single-dose, Randomized, two-Period, Cross over Study...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT01064232
Treatments Being Tested
A review of the amount of drug in your blood over time....
Status
Completed
Location
Neuropsychiatric Research Center of Orange County
Start Date
2014-07
Trial ID
NCT02186769
Treatments Being Tested
The purpose of this study is to compare the effectiveness of two antipsycho...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00299702
Treatments Being Tested
This study will determine the efficacy of oral risperidone (Risperdal) vers...
Status
Completed
Location
UCLA Semel Institute for Neuroscience and Human Behavior
Start Date
2011-10
Trial ID
NCT01451736
Treatments Being Tested